Back to GetFilings.com



 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the quarterly period ended September 30, 2003

 

OR

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

 

For the transition period from                         to                         

 

Commission file number 000-25571

 

AXONYX INC.

(Exact name of registrant as specified in its charter)

 

NEVADA

 

86-0883978

(State or other jurisdiction of incorporation
or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

500 SEVENTH AVENUE, 10TH FLOOR, NEW YORK, NEW YORK  10018

(Address of principal executive offices)  (Zip Code)

 

 

 

(212) 645-7704

(Registrant’s telephone number, including area code)

 

 

 

 

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ý  No  o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).  Yes  o  No  ý

 

As of October 31, 2003, there were 33,300,600 shares of the registrant’s common stock outstanding.

 

 



 

AXONYX INC.

 

INDEX

 

PART I.

FINANCIAL INFORMATION

 

 

Item 1.

Condensed Consolidated Financial Statements

 

 

 

Condensed Consolidated Balance Sheets as of September 30, 2003 (unaudited) and December 31, 2002 (audited)

 

 

 

Condensed Consolidated Statements of Operations (unaudited) for the three and nine months ended September 30, 2003 and 2002

 

 

 

Condensed Consolidated Statements of Changes in Stockholders’ Equity (unaudited) for the nine months ended September 30, 2003

 

 

 

Condensed Consolidated Statements of Cash Flows (unaudited) for the nine months ended September 30, 2003 and 2002

 

 

 

Notes to Condensed Consolidated Financial Statements

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

Item 4.

Controls and Procedures

 

 

PART II.

OTHER INFORMATION

 

 

Item 2.

Changes in Securities and Use of Proceeds

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

2



 

PART I. FINANCIAL INFORMATION

 

Item 1. Consolidated Financial Statements

 

AXONYX INC.

 

Condensed Consolidated Balance Sheets

 

 

 

September 30,
2003

 

December 31,
2002

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

Cash and cash equivalents

 

$

30,014,000

 

$

3,021,000

 

Cash held in escrow

 

 

 

1,453,000

 

Stock subscriptions receivable

 

 

 

3,415,000

 

Other current assets

 

46,000

 

8,000

 

 

 

 

 

 

 

Total current assets

 

30,060,000

 

7,897,000

 

 

 

 

 

 

 

Equipment, net

 

25,000

 

37,000

 

 

 

 

 

 

 

Security deposit

 

6,000

 

50,000

 

 

 

 

 

 

 

 

 

$

30,091,000

 

$

7,984,000

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable and accrued expenses

 

$

882,000

 

$

1,335,000

 

Total liabilities

 

882,000

 

1,335,000

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY

 

 

 

 

 

Preferred stock - $.001 par value, 15,000,000 shares authorized; none issued

 

 

 

 

 

Common Stock - $.001 par value, 75,000,000 shares authorized; 33,249,699 and 23,733,613 shares issued and outstanding.

 

33,000

 

24,000

 

Additional paid-in capital

 

59,422,000

 

32,247,000

 

Accumulated deficit

 

(30,246,000

)

(25,622,000

)

 

 

 

 

 

 

Total stockholders’ equity

 

29,209,000

 

6,649,000

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

30,091,000

 

$

7,984,000

 

 

See notes to condensed consolidated financial statements.

 

3



 

AXONYX INC.

 

Condensed Consolidated Statements of Operations

(unaudited)

 

 

 

Three months ended
September 30,

 

Nine months ended
September 30,

 

 

 

2003

 

2002

 

2003

 

2002

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

 

$

 

$

1,000,000

 

$

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

986,000

 

980,000

 

3,262,000

 

3,104,000

 

General and administrative

 

844,000

 

526,000

 

2,434,000

 

1,989,000

 

 

 

1,830,000

 

1,506,000

 

5,696,000

 

5,093,000

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

(1,830,000

)

(1,506,000

)

(4,696,000

)

(5,093,000

)

 

 

 

 

 

 

 

 

 

 

Foreign exchange

 

5,000

 

(1,000

)

13,000

 

1,000

 

Interest income

 

22,000

 

18,000

 

59,000

 

85,000

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(1,803,000

)

$

(1,489,000

)

$

(4,624,000

)

$

(5,007,000

)

 

 

 

 

 

 

 

 

 

 

Net loss per common share

 

$

(0.07

)

$

(0.09

)

$

(0.18

)

$

(0.29

)

 

 

 

 

 

 

 

 

 

 

Weighted average shares-basic and diluted

 

27,398,419

 

17,247,371

 

25,107,598

 

17,247,371